Kalaris Therapeutics (KLRS) Earnings Analysis
Kalaris Therapeutics (KLRS) next reports earnings on 2026-08-12, consensus EPS -0.5 USD. Last quarter (2026-03-17) it beat with EPS -0.44 USD vs -0.56 USD est (+21.4%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -1.89.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does KLRS next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.5 USD |
| Revenue estimate | n/a |
KLRS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-17 | -0.44 USD | -0.56 USD | +21.4% | Beat |
| 2025-08-13 | -0.61 USD | -0.51 USD | -19.6% | Miss |
| 2025-05-14 | -2.52 USD | -0.78 USD | -223.1% | Miss |
| 2025-03-07 | -3.63888 USD | -2.76 USD | -31.8% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
KLRS valuation and analyst view
| Trailing P/E | -1.89 |
|---|---|
| Trailing EPS | -1.85882 USD |
| Price / book | 1.41 |
| Dividend yield | 0.00% |
| Market cap | 0.07B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
| Avg price target | 17 USD |
Related research pages
Frequently asked questions
When is Kalaris Therapeutics (KLRS)'s next earnings date?
Kalaris Therapeutics is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.5 USD.
Did KLRS beat earnings last quarter?
In its 2026-03-17 report, KLRS posted EPS of -0.44 USD versus a -0.56 USD estimate — a beat of 21.4%.
What is KLRS's earnings track record?
Over the last 4 reported quarters with consensus data, KLRS beat estimates 1 times (25%).
What is KLRS's current P/E ratio and EPS?
KLRS trades at a trailing P/E of -1.89 on trailing EPS of -1.8588227141408196 USD.
What do analysts rate KLRS?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 17 USD.